Literature DB >> 25568262

A rare but potentially fatal cause of diarrhoea and weight loss: enteropathy-associated T-cell lymphoma.

Gorav Neel Wali1, Helen Elizabeth Jane Tyrrell1, Graham P Collins2, Helen J Eagleton1.   

Abstract

Enteropathy-associated T-cell lymphoma (EATL) is a rare but potentially fatal cause of diarrhoea and weight loss. EATL commonly presents with abdominal pain, diarrhoea and weight loss, but can also present with complications such as bowel obstruction and perforation. It is a tumour of intraepithelial lymphocytes that occurs in a relatively young population. It is the most common neoplastic complication of coeliac disease, but can occur with no prior diagnosis of coeliac disease. This case demonstrates the difficulties that can be faced in diagnosing this disorder, particularly when there is no preceding history of coeliac disease. Early diagnosis is of utmost importance in order to start treatment before the effects of malnutrition increase the risk of complications from chemotherapy. Hence awareness of the condition among general medical physicians, to whom it will often present first, is essential. However, even with prompt diagnosis, outcomes for this condition remain poor. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2015        PMID: 25568262      PMCID: PMC4289796          DOI: 10.1136/bcr-2014-204125

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  22 in total

Review 1.  Enteropathy-associated T-cell lymphoma.

Authors:  Andrés J M Ferreri; Pier Luigi Zinzani; Silvia Govi; Stefano A Pileri
Journal:  Crit Rev Oncol Hematol       Date:  2010-07-23       Impact factor: 6.312

Review 2.  Celiac disease.

Authors:  Peter H R Green; Christophe Cellier
Journal:  N Engl J Med       Date:  2007-10-25       Impact factor: 91.245

Review 3.  Guidelines for the management of mature T-cell and NK-cell neoplasms (excluding cutaneous T-cell lymphoma).

Authors:  Claire E Dearden; Rod Johnson; Ruth Pettengell; Stephen Devereux; Kate Cwynarski; Sean Whittaker; Andrew McMillan
Journal:  Br J Haematol       Date:  2011-04-11       Impact factor: 6.998

4.  Autologous hematopoietic stem cell transplantation in refractory celiac disease with aberrant T cells.

Authors:  Abdulbaqi Al-toma; Otto J Visser; Hyacintha M van Roessel; B Mary E von Blomberg; Wieke H M Verbeek; Petra E T Scholten; Gert J Ossenkoppele; Peter C Huijgens; Chris J J Mulder
Journal:  Blood       Date:  2006-10-26       Impact factor: 22.113

5.  Brentuximab in the treatment of CD30-positive enteropathy-associated T-cell lymphoma.

Authors:  Waleed F Khalaf; Meghan E Caldwell; Nishitha Reddy
Journal:  J Natl Compr Canc Netw       Date:  2013-02-01       Impact factor: 11.908

Review 6.  Enteropathy associated T-cell lymphoma and its precursor lesions.

Authors:  Jolanda M W van de Water; Saskia A G M Cillessen; Otto J Visser; Wieke H M Verbeek; Chris J L M Meijer; Chris J J Mulder
Journal:  Best Pract Res Clin Gastroenterol       Date:  2010-02       Impact factor: 3.043

7.  Allogeneic haematopoietic stem-cell transplantation for relapsed and refractory aggressive histology non-Hodgkin lymphoma.

Authors:  Richard T Doocey; Cynthia L Toze; Joseph M Connors; Thomas J Nevill; Randy D Gascoyne; Michael J Barnett; Donna L Forrest; Donna E Hogge; Julye C Lavoie; Stephen H Nantel; John D Shepherd; Heather J Sutherland; Nicholas J Voss; Clayton A Smith; Kevin W Song
Journal:  Br J Haematol       Date:  2005-10       Impact factor: 6.998

8.  Enteropathy-type intestinal T-cell lymphoma: clinical features and treatment of 31 patients in a single center.

Authors:  J Gale; P D Simmonds; G M Mead; J W Sweetenham; D H Wright
Journal:  J Clin Oncol       Date:  2000-02       Impact factor: 44.544

Review 9.  Association of celiac disease and intestinal lymphomas and other cancers.

Authors:  Carlo Catassi; Italo Bearzi; Geoffrey K T Holmes
Journal:  Gastroenterology       Date:  2005-04       Impact factor: 22.682

10.  International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes.

Authors:  Julie Vose; James Armitage; Dennis Weisenburger
Journal:  J Clin Oncol       Date:  2008-07-14       Impact factor: 44.544

View more
  2 in total

1.  Type II Enteropathy-Associated T-cell Lymphoma: A Rare Report from Iran.

Authors:  Neda Nozari
Journal:  Middle East J Dig Dis       Date:  2017-01

2.  Use of PEG-asparaginase in monomorphic epitheliotropic intestinal T-cell lymphoma, a disease with diagnostic and therapeutic challenges.

Authors:  Cesar Gentille; Qian Qin; Andreia Barbieri; Pingali Sai Ravi; Swaminathan Iyer
Journal:  Ecancermedicalscience       Date:  2017-09-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.